Industry news 2026-07-17 09:00:00 52 views admin

The neck is the most mechanically demanding region of the spine: 7 vertebrae carrying a 4-5 kg head through 600+ movement cycles per waking hour. A patch that works on a knee or lower back often fails on the neck because the application area is smaller, the skin thinner, the underlying structures closer to the surface, and the wear context (sitting at a desk, driving) restricts patch size. This article compares six patch types specifically engineered for cervical application — menthol, methyl salicylate, lidocaine, capsaicin, diclofenac, and TENS-electrode — and gives B2B buyers the spec sheet for an OEM factory.
Three anatomical facts make the cervical region unlike any other patch application site. First, the skin is thinner (0.5-0.8 mm versus 1.5-2.0 mm on the lower back), so transdermal flux is 2-3 fold higher for any given concentration. Second, the underlying muscles — upper trapezius, levator scapulae, splenius capitis — are small (1-3 cm thick) and tightly layered, so even a 10x14 cm patch may overlie 5-6 muscle groups with competing pain sources. Third, the wear context restricts adhesive choice: a desk worker cannot tolerate the bulk of a large occlusive patch under a collar, and a driver cannot have menthol vapor reaching the eyes from a chest-adjacent application.
The practical implication for an OEM buyer: a "neck pain patch" is not a smaller back-pain patch. It needs a thinner backing film, lower-profile adhesive, smaller footprint (typically 7x10 cm or 5x7 cm), and a formulation tuned for higher skin sensitivity.
| Type | Active | Sensation | Best cervical indication | Onset |
|---|---|---|---|---|
| Menthol cooling patch | Menthol 5-10% | Cooling | Acute muscle strain, tech-neck tension | 1-5 min |
| Methyl salicylate warming patch | Methyl salicylate 10-20% | Warming | Chronic cervical arthritis, morning stiffness | 10-30 min |
| Lidocaine 4% patch | Lidocaine 4% | Numbness | Cervicogenic headache, post-whiplash nerve pain | 30-60 min |
| Capsaicin patch (low-dose) | Capsaicin 0.025% | Initial warmth then relief | Chronic cervical radiculopathy (under clinical supervision) | 3-7 days |
| Diclofenac hydrogel patch | Diclofenac 1% (Rx in US, OTC in EU) | Silent anti-inflammatory | Cervical osteoarthritis with active inflammation | 1-2 h |
| TENS electrode patch | Electrical (no drug) | Tingling / pulsing | Trapezius spasm, referred shoulder pain | Immediate |
Menthol activates the TRPM8 cold receptor on free nerve endings, producing a cooling sensation that competes with pain signals via the spinal gate-control pathway. In the cervical region, menthol's fast onset (1-5 minutes) makes it the best choice for acute tech-neck tension or post-driving stiffness.
Methyl salicylate is a topical salicylate that produces both counter-irritant warming and local COX inhibition. The warming effect derives from TRPV1 activation by salicylate's hydroxy-benzoate metabolite; the anti-inflammatory effect comes from local prostaglandin suppression. In cervical osteoarthritis, methyl salicylate's dual mechanism outperforms menthol because the pain has both a muscular component (responds to warming) and an inflammatory component (responds to COX inhibition).
Lidocaine 4% blocks voltage-gated sodium channels on peripheral nerve fibers, producing numbness without systemic effects. For cervicogenic headache and post-whiplash nerve pain, lidocaine's silent numbing avoids the menthol cooling that can trigger referred sensitivity in the occipital region. A 2018 randomized crossover study in Pain Medicine (Yilmaz et al., vol. 19, no. 8, pp. 1592-1599) compared lidocaine 5% medicated plaster to placebo in 60 patients with chronic cervical radiculopathy; the lidocaine group showed 38% greater pain reduction at 4 weeks.
Capsaicin at low OTC doses (0.025%) produces initial TRPV1 activation and warmth, then depletes substance P from peripheral nerve terminals over 3-7 days of repeated use. The chronic-radiculopathy use case requires clinical supervision, but the OTC patch format makes daily home use practical.
Diclofenac 1% hydrogel patch (OTC in EU under EMA guidance, Rx in US) provides topical NSAID delivery without gastrointestinal side effects of oral diclofenac. For cervical osteoarthritis with active synovial inflammation, diclofenac outperforms menthol and methyl salicylate because it addresses the inflammatory driver directly. A 2015 Cochrane review (Derry et al., Cochrane Database of Systematic Reviews, CD007402) found topical diclofenac superior to placebo for osteoarthritis pain with number-needed-to-treat of 5.0.
TENS-electrode patches deliver transcutaneous electrical nerve stimulation through hydrogel electrodes, modulating pain signals via both spinal gating and endogenous opioid release. The cervical application is well-tolerated because the muscle is superficial and the electrode can be placed along the paraspinal line without crossing the carotid sinus anteriorly.
| Cervical region | Apply | Avoid |
|---|---|---|
| Posterior paraspinal (C2-C7) | Yes - primary indicated site | Avoid directly over the spine if MR-implant present |
| Upper trapezius (shoulder-to-neck) | Yes - most common consumer site | Avoid across the supraclavicular fossa |
| Levator scapulae (medial scapular border) | Yes - referred pain site | Rotate sites if used daily |
| Occipital ridge (skull base) | Yes for cervicogenic headache | Avoid above the hairline (poor adhesion) |
| Anterior neck (carotid triangle) | No | Always avoid - carotid sinus and airway |
| Thyroid cartilage region | No | Avoid - skin is highly sensitive; airway proximity |
| Lymph node chains | No | Avoid - unknown absorption through inflamed tissue |
| Parameter | Cervical spec | Standard body patch (for comparison) |
|---|---|---|
| Patch size | 7 x 10 cm or 5 x 7 cm (contoured) | 10 x 14 cm |
| Backing material thickness | 0.15-0.20 mm (low-profile) | 0.25-0.35 mm |
| Backing material | Elastic non-woven (conforms to neck curvature) | Standard non-woven |
| Adhesive | Medical-grade acrylic, low-tack (10-15 N/25mm peel) | Standard acrylic (20-30 N/25mm peel) |
| Edge taper | Beveled or rounded (no shirt-collar lift) | Square cut |
| Active concentration (menthol) | 5-10% (lower due to thin skin) | 5-16% |
| Active concentration (methyl salicylate) | 10-20% | 10-30% |
| Wear time | 4-6 h (desk context) | 8-12 h |
| MOQ | 30,000 patches (custom shape) | 20,000 patches |
| Lead time | 35-50 days (custom die-cut) | 30-45 days |
| Certifications | GMP (NMPA), ISO 13485, CE MDR, US FDA OTC monograph | Same |
Henan Hanmeng Bio-Tech runs all three steps in-house at its GMP-certified facility in Henan, China, with ISO 13485 quality management and full support for FDA OTC monograph, CE MDR, and NMPA filing. Custom cervical-specific sizes, beveled-edge tooling, and concentration variants are available on every production tier.
For the full cervical pain-patch spec sheet — including size options, concentration ceilings, and custom die-cut tooling — visit the Henan Hanmeng Bio-Tech neck pain patch OEM page.
QQ: 396269538
Phone: 17796669065
Tel: 17796669065
Email: 396269538
Add: Room 001, 1st Floor, Building 1, Zhengzhou Hangmei International Smart City, Intersection of S102 and Nanquan Road, Xuedian Town, Xinzheng City, Zhengzhou, Henan Province, China